Emerging advances in P-glycoprotein inhibitory nanomaterials for drug delivery-Reference-Cited by-同舟云学术

Emerging advances in P-glycoprotein inhibitory nanomaterials for drug delivery

Published:2018-09-02 Issue:9 Volume:15 Page:869-879
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Kou Longfa¹,Sun Rui¹,Bhutia Yangzom D.²,Yao Qing³,Chen Ruijie¹

Affiliation:

1. Department of Pharmacy, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, People’s Republic of China

2. Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX, USA

3. Department of Pharmaceutics, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang Province, People’s Republic of China

Funder

National Natural Science Foundation of China

Start-up funds from the Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2018.1517749

Reference96 articles.

1. A novel alanine to serine substitution mutation in SoxS induces overexpression of efflux pumps and contributes to multidrug resistance in clinical Escherichia coli isolates

2. Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines

3. Interleukin-6: A Critical Cytokine in Cancer Multidrug Resistance

4. Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. M1 macrophage-membrane-cloaked paclitaxel/β-elemene nanoparticles targeting cervical cancer for enhanced therapy;International Journal of Pharmaceutics: X;2024-12

2. Drug Nanocrystals in Oral Absorption: Factors That Influence Pharmacokinetics;Pharmaceutics;2024-08-29

3. Mechanistic insights into cisplatin response in breast tumors: Molecular determinants and drug/nanotechnology-based therapeutic opportunities;Mutation Research - Reviews in Mutation Research;2024-07

4. Fine particulate matter (PM2.5) promotes chemoresistance and aggressive phenotype of A549 lung cancer cells;Toxicology and Applied Pharmacology;2024-06

5. Study on the Effect of Pharmaceutical Excipient PEG400 on the Pharmacokinetics of Baicalin in Cells Based on MRP2, MRP3, and BCRP Efflux Transporters;Pharmaceutics;2024-05-29